Arlene Morris

Director · 5 filings · Latest: Aug 27, 2026

Cogent Biosciences, Inc.

Edgewise Therapeutics, Inc.

PALATIN TECHNOLOGIES INC

Viridian Therapeutics, Inc.\DE

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
COGT	Arlene Morris	Director	Aug 27, 2026	Sale	$37.12	45,510	$1.7M	0	Aug 31 9:01 PM
COGT	Arlene Morris	Director	Aug 27, 2026	Option Exercise	$5.39	45,510	$245.5K	45,510	Aug 31 9:01 PM
COGT	ARLENE MORRIS	—	Aug 27, 2026	Proposed Sale	$36.72	45,510	$1.7M	—	Aug 27 8:17 PM